Scientific Poster

Comparison of Two Commercially Available T-Cell Receptor Sequencing Assays

AACR 2020 Poster

Deep sequencing of the T-cell receptor complementarity-determining regions (CDR)3 assists with resolving T-cell diversity, and, in oncology, detects specific clones or changes in clonality associated with anti-tumor immune responses. However, the extreme diversity of the T-cell receptor repertoire represents a major analytical challenge, as a gold standard method for repertoire analysis has not yet been identified. Outlined in this poster is a performance evaluation of the Oncomine™ TCRβ LR (long read) and SR (short read) assays in PBMC and formalin-fixed paraffin-embedded (FFPE) tissues, as well as a comparison to another commercially available TCR sequencing assay. Download poster to learn more.

Related Services:

Clinical Trial Genomics Laboratory Services

A tour of our genomics laboratory

T-cell Receptor (TCR) Sequencing Assay for Characterization of Adaptive Immune Response

Detects TCRβ and TCRγ clonotypes expressed at the mRNA level

Genomics Laboratory Sequencing Capabilities

Global genomic testing services to support drug discovery, precision medicine, and clinical development

Microsatellite Instability Assay for Response to Immunotherapy

MSI assay for sensitive detection of 5 mononucleotide repeat markers in tumor FFPE specimens

Read More